個股熱度排行 | 4月7日港股收盤
根據uSMART輿情監測數據，7日港股交易時段，市場關注指數最高的4只股票是百威亞太、中國國航、富力地產、開拓藥業-B。
4月7日—港股關注排行TOP4
百威亞太
關注度第一爲百威亞太，該股今日收盤下跌3.82%，報於19.62港元。近5個交易日累計下跌6.57%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
麥格理下調百威亞太目標價至28.4元 評級「跑贏大市」
百威亞太跌超4% 國內銷量下降及平均售價降低 麥格理下調目標價9%
中國國航
關注度第二爲中國國航，該股今日收盤下跌2.28%，報於5.56港元。近5個交易日累計下跌0.18%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
大和下調中國國航目標價4.4% 料其近期客運需求復甦因疫情受阻
大和削中國國航目標價4.4%至6.5港元 重申“買入”評級
富力地產
關注度第三爲富力地產，該股今日收盤下跌4.50%，報於3.18港元。近5個交易日累計上漲12.77%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
富力地產：“19富力02”存續期後2年票息仍爲6.48%
富力地產：“19富力02”存續期後2年票面利率固定不變
開拓藥業-B
關注度第四爲開拓藥業-B，該股今日收盤下跌24.78%，報於21.70港元。近5個交易日累計上漲96.20%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
開拓藥業高開低走挫逾13% 日內振幅達25.82%
多數生物醫藥股下挫走弱 開拓藥業跌13.34%
此外，監測期內有1只股票的輿情出現大扭轉，意味着在消息面上出現了可能影響公司股價趨勢的事件或者轉折。
4月7日—港股輿情轉折預警
開拓藥業-B
開拓藥業-B輿情扭轉指數達99，目前輿情方向爲利空，表明公司出現了被投資者視作較大利空的消息。
其中較被市場關注的消息有：
開拓藥業高開低走挫逾13% 日內振幅達25.82%
多數生物醫藥股下挫走弱 開拓藥業跌13.34%
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
